DTIL
Price
$5.13
Change
-$0.02 (-0.39%)
Updated
May 9 closing price
Capitalization
54.12M
RXRX
Price
$4.33
Change
-$0.06 (-1.37%)
Updated
May 9 closing price
Capitalization
1.76B
93 days until earnings call
Ad is loading...

DTIL vs RXRX

Header iconDTIL vs RXRX Comparison
Open Charts DTIL vs RXRXBanner chart's image
Precision BioSciences
Price$5.13
Change-$0.02 (-0.39%)
Volume$96.09K
Capitalization54.12M
Recursion Pharmaceuticals
Price$4.33
Change-$0.06 (-1.37%)
Volume$14.83M
Capitalization1.76B
DTIL vs RXRX Comparison Chart
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. RXRX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (DTIL: $5.13 vs. RXRX: $4.33)
Brand notoriety: DTIL and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 61% vs. RXRX: 72%
Market capitalization -- DTIL: $54.12M vs. RXRX: $1.76B
DTIL [@Biotechnology] is valued at $54.12M. RXRX’s [@Biotechnology] market capitalization is $1.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • DTIL’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than RXRX.

Price Growth

DTIL (@Biotechnology) experienced а -10.31% price change this week, while RXRX (@Biotechnology) price change was -24.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

DTIL is expected to report earnings on Mar 26, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.76B) has a higher market cap than DTIL($54.1M). DTIL YTD gains are higher at: 34.646 vs. RXRX (-35.947). DTIL has higher annual earnings (EBITDA): 18.8M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. DTIL (101M). DTIL has less debt than RXRX: DTIL (30.3M) vs RXRX (108M). DTIL has higher revenues than RXRX: DTIL (75.1M) vs RXRX (58.5M).
DTILRXRXDTIL / RXRX
Capitalization54.1M1.76B3%
EBITDA18.8M-426.72M-4%
Gain YTD34.646-35.947-96%
P/E Ratio4.93N/A-
Revenue75.1M58.5M128%
Total Cash101M594M17%
Total Debt30.3M108M28%
FUNDAMENTALS RATINGS
DTIL: Fundamental Ratings
DTIL
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DTILRXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GHI11.590.21
+1.85%
Greystone Housing Impact Investors LP
WKC26.790.23
+0.87%
World Kinect Corp
ALK52.03-0.74
-1.40%
Alaska Air Group
BTI41.64-1.66
-3.83%
British American Tobacco plc
FAT2.75-0.13
-4.51%
FAT Brands